1-5 of 5
Paul A. Hamlin
Close
Sort by
Journal Articles

Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP

Clinical Trials & Observations
Kurt S. Bantilan, Alexandra N. Smith, Matthew J. Maurer, Julie Teruya-Feldstein, Matthew J. Matasar, Alison J. Moskowitz, David J. Straus, Ariela Noy, M. Lia Palomba, Steven M. Horwitz, Paul A. Hamlin, Carol S. Portlock, James R. Cerhan, Thomas M. Habermann, Gilles A. Salles, Grzegorz S. Nowakowski, Craig H. Moskowitz, Andrew D. Zelenetz
Journal: Blood Advances
Blood Adv (2024) 8 (9): 2172–2181.
https://doi.org/10.1182/bloodadvances.2023011408
Published: 2024
Includes: Supplemental data
Journal Articles

Retrospective characterization of nodal marginal zone lymphoma

Robert Stuver, Esther Drill, David Qualls, Michelle Okwali, Connie Lee Batlevi, Philip C. Caron, Ahmet Dogan, Zachary D. Epstein-Peterson, Lorenzo Falchi, Paul A. Hamlin, Steven M. Horwitz, Brandon S. Imber, Andrew M. Intlekofer, William T. Johnson, Niloufer Khan, Anita Kumar, Oscar B. Lahoud, Jennifer Kimberly Lue, Matthew J. Matasar, Alison J. Moskowitz, Ariela Noy, Colette N. Owens, M. Lia Palomba, Heiko Schöder, Santosha A. Vardhana, Joachim Yahalom, Andrew D. Zelenetz, Gilles Salles, David J. Straus
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4838–4847.
https://doi.org/10.1182/bloodadvances.2022009587
Published: 2023
Includes: Supplemental data
Journal Articles

Prospective geriatric assessment and geriatric consultation in CAR T-cell therapy for older patients with lymphoma

Clinical Trials & Observations
Richard J. Lin, Soo Jung Kim, Samantha Brown, Theresa A. Elko, Josel D. Ruiz, Danielle M. Hanley, M. Lia Palomba, Miguel-Angel Perales, Gunjan L. Shah, Parastoo B. Dahi, Michael Scordo, Craig S. Sauter, Connie L. Batlevi, Ana Alarcon Tomas, Roni Shouval, Nicole Lee, Emma A. Pavkovic, Danielle E. Engstler, Jae H. Park, Gilles A. Salles, Sean M. Devlin, Beatriz Korc-Grodzicki, Paul A. Hamlin, Sergio A. Giralt
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3501–3505.
https://doi.org/10.1182/bloodadvances.2023010003
Published: 2023
Includes: Supplemental data
Journal Articles

Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: is 4 Gy suitable for curable patients?

Clinical Trials & Observations
Brandon S. Imber, Karen W. Chau, Jasme Lee, Jisun Lee, Dana L. Casey, Joanna C. Yang, N. Ari Wijentunga, Annemarie Shepherd, Carla Hajj, Shunan Qi, Monica R. Chelius, Paul A. Hamlin, M. Lia Palomba, Erel Joffe, Zhigang Zhang, Andrew D. Zelenetz, Gilles A. Salles, Joachim Yahalom
Journal: Blood Advances
Blood Adv (2021) 5 (20): 4185–4197.
https://doi.org/10.1182/bloodadvances.2021004939
Published: 2021
Includes: Supplemental data
Journal Articles

Toxicities of high-dose chemotherapy and autologous hematopoietic cell transplantation in older patients with lymphoma

Clinical Trials & Observations
Parastoo B. Dahi, Jasme Lee, Sean M. Devlin, Josel Ruiz, Molly Maloy, Carlos Rondon-Clavo, Erica Petrlik, Roni Tamari, Gunjan Shah, Michael Scordo, Matthew J. Matasar, Paul A. Hamlin, Esperanza Papadopoulos, Ann A. Jakubowski, Miguel-Angel Perales, Craig H. Moskowitz, Craig S. Sauter, Sergio A. Giralt
Journal: Blood Advances
Blood Adv (2021) 5 (12): 2608–2618.
https://doi.org/10.1182/bloodadvances.2020004167
Published: 2021
Includes: Supplemental data